VK
Vivek Kaler
About Vivek Kaler
Data last updated:
Vivek Kaler is a Director at Safe And Cure Superspecialities Hospital Private Limited (since 2018), Director at Shree Krishnam Yrv Buildcon Private Limited (since 2013) and Director at Tenfold Pharmaceuticals Private Limited (since 2005), and holds 5 more current directorships. The companies operate in Healthcare, Real Estate and Construction and Pharma. The 7 current companies with reported revenue have a combined latest revenue of ₹7.10 Cr; the largest is Safe And Cure Superspecialities Hospital Private Limited at ₹2.60 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Jul 2018 | 2018 | ₹2.60 Cr (FY 2023) | Active | |
| Director | 30 Apr 2013 | 2013 | ₹2.43 Cr (FY 2024) | Active | |
| Director | 13 Sep 2005 | 2005 | ₹86.7 Lakh (FY 2025) | Active | |
| Additional Director | 23 Jul 2012 | 2008 | ₹84.6 Lakh (FY 2025) | Active | |
| Director | 10 Nov 2004 | 1994 | ₹34.7 Lakh (FY 2023) | Active | |
| Director | 01 May 2018 | 2018 | ₹97,847 (FY 2024) | Active | |
| Director | 20 Jan 2011 | 2011 | ₹51,660 (FY 2023) | Active | |
| Director | 17 Dec 2012 | 2012 | Active |
Board colleagues of Vivek Kaler
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vivek Kaler
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivek Kaler
Vivek Kaler currently holds 8 directorships: Safe And Cure Superspecialities Hospital Private Limited (Director, since 12 Jul 2018, revenue ₹2.60 Cr (FY 2023)); Shree Krishnam Yrv Buildcon Private Limited (Director, since 30 Apr 2013, revenue ₹2.43 Cr (FY 2024)); Tenfold Pharmaceuticals Private Limited (Director, since 13 Sep 2005, revenue ₹86.7 Lakh (FY 2025)); Rex Pumps Private Limited (Additional Director, since 23 Jul 2012, revenue ₹84.6 Lakh (FY 2025)); Deevee Marbles Private Limited (Director, since 10 Nov 2004, revenue ₹34.7 Lakh (FY 2023)); and 3 more.
Vivek Kaler was first appointed on 10 Nov 2004 as Director at Deevee Marbles Private Limited. The most recent appointment on record is 12 Jul 2018 at Safe And Cure Superspecialities Hospital Private Limited.
The 7 current companies of Vivek Kaler that report revenue have a combined latest revenue of ₹7.10 Cr: Safe And Cure Superspecialities Hospital Private Limited ₹2.60 Cr (FY 2023); Shree Krishnam Yrv Buildcon Private Limited ₹2.43 Cr (FY 2024); Tenfold Pharmaceuticals Private Limited ₹86.7 Lakh (FY 2025); Rex Pumps Private Limited ₹84.6 Lakh (FY 2025); Deevee Marbles Private Limited ₹34.7 Lakh (FY 2023); and 2 more.
The current boards of Vivek Kaler's companies include Hardeo Ram Kaler (Safe And Cure Superspecialities Hospital Private Limited), Radha Devi Kaler (Safe And Cure Superspecialities Hospital Private Limited), Sucheta Kaler (Safe And Cure Superspecialities Hospital Private Limited), Raj Kumar Golechha (Shree Krishnam Yrv Buildcon Private Limited), Satish Kumar Singodiya (Shree Krishnam Yrv Buildcon Private Limited), Sunil Singodiya (Shree Krishnam Yrv Buildcon Private Limited), among others.